Your session is about to expire
← Back to Search
Imaging
Imaging Panel for Prostate Cancer (IGPC-2 Trial)
N/A
Waitlist Available
Led By Dr. Glenn Bauman, MD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within two years of study completion
Awards & highlights
IGPC-2 Trial Summary
This trial is testing a new way to map prostate cancer, to see if it's more accurate than the standard of care.
Eligible Conditions
- Prostate Cancer
IGPC-2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within two years of study completion.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within two years of study completion.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hybrid Imaging Map (HIM) Validation
Other outcome measures
MRI Prostate Sodium Imaging Validation
IGPC-2 Trial Design
1Treatment groups
Experimental Treatment
Group I: Imaging PanelExperimental Treatment1 Intervention
Patients who provided written informed consent and found to be eligible for study were asked to complete Positron Emission Tomography (PET) + Dynamic CT imaging, PET/MRI (with endorectal coil) and 3D-Transrectal ultrasound prior to standard of care radical prostatectomy.
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
656 Previous Clinical Trials
413,376 Total Patients Enrolled
15 Trials studying Prostate Cancer
593 Patients Enrolled for Prostate Cancer
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,340 Previous Clinical Trials
26,452,646 Total Patients Enrolled
7 Trials studying Prostate Cancer
1,984 Patients Enrolled for Prostate Cancer
Dr. Glenn Bauman, MDPrincipal InvestigatorLawson Health Research Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have received treatment for prostate cancer before, except for radiation therapy (Cohort 2 only).You cannot have an MRI scan due to a medical reason.You have an electronic device such as a pacemaker implanted in your body.You have metal in your eye socket.You have a clip in your brain to treat an aneurysm.
Research Study Groups:
This trial has the following groups:- Group 1: Imaging Panel
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals still being welcomed to participate in this scientific experiment?
"According to clinicaltrials.gov, this medical study is not presently looking for participants. Initially posted on 2/12/2012 and most recently edited on 12/14/2021, there are no recruitment opportunities currently available; however, over 1300 other trials have open enrollment at the moment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger